Related Experiment Video
Updated: Jun 13, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
Stem cells as vectors for antitumour therapy
Michael R Loebinger1, Sam M Janes
1Centre For Respiratory Research, Rayne Institute, University College London, 5 University Street, London WC1E 6JJ, UK.
Abstract:
Recent research suggests that mesenchymal stem cells (MSCs) are able to migrate specifically to tumours and their metastases throughout the body. This has led to considerable excitement about the possibility of modifying these cells to express anticancer molecules and using them as specific targeted anticancer agents. However, there are concerns that systemically delivered MSCs may have non-desirable effects, and there are also many unanswered questions including the mechanism of tumour homing. This review investigates the different MSC-delivered anticancer agents, addresses the questions and concerns, and tries to place this potential therapy in future cancer management.
Insights
Mesenchymal stem cells (MSCs) show promise for targeted cancer therapy by migrating to tumors. This review explores MSC-based anticancer agents, addressing safety concerns and future applications in cancer management.
Area of Science:
- Oncology
- Stem Cell Biology
- Cancer Therapy
Background:
- Mesenchymal stem cells (MSCs) exhibit inherent tumor-homing capabilities.
- MSCs can be engineered to deliver therapeutic payloads, offering targeted cancer treatment potential.
- Concerns exist regarding systemic delivery of MSCs and the precise mechanisms of tumor homing.
Purpose of the Study:
- To review various anticancer agents delivered by MSCs.
- To address safety concerns and unanswered questions surrounding MSC-based cancer therapy.
- To evaluate the future role of MSCs in cancer management.
Main Methods:
- Literature review of studies on MSC-delivered anticancer agents.
- Analysis of research addressing MSC tumor homing mechanisms.
- Discussion of potential benefits and risks of MSC-based cancer therapies.
Main Results:
- Several types of MSC-delivered anticancer agents have been investigated.
- The exact mechanisms of MSC tumor homing require further elucidation.
- Potential for MSCs as targeted delivery vehicles for cancer treatment is significant but requires careful consideration of safety.
Conclusions:
- MSCs hold promise as targeted anticancer agents.
- Further research is needed to optimize MSC delivery and address safety concerns.
- MSC-based therapies could become a valuable component of future cancer management strategies.
More Related Videos
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Stem Cell Culture
iPS Cell Differentiation

